Not everything is Zika: Congenital toxoplasmosis, still prevalent in Colombia?
- Jorge L. Alvarado-Socarras,
- Keyla Meneses-Silvera,
- Andrea Carolina Zarate-Vergara,
- Carlos Guerrero-Gomez,
- Alfonso J. Rodriguez-Morales(corresponding author)
- Organización Latinoamericana para el Fomento de la Investigación en Salud (OLFIS),
- Fundación Cardiovascular de Colombia,
- Red Colombiana de Colaboración en Zika y otros Arbovirus (RECOLZIKA),
- Universidad de Santander,
- Universidad Tecnológica de Pereira
Open access
Publication Information
Output type
Original language
SpanishPages from-to (Number of pages)
Pages 332-336 (5 pages)Journal (Volume, Issue Number)
Revista Peruana de Medicina Experimental y Salud Publica (Volume 34, Issue 2)Publication milestones
- Published - 01/04/2017
Publication status
ISSN
1726-4634Publication IDs
- Scopus: 85028989553
- PubMed: 29177397
Abstract
Congenital toxoplasmosis continues to be a public health threat. Even existing guidelines, publicly known, its implementation and lack of appropriate interpretation of serological tests in pregnancy is often observed. This leds to failure in opportunities for positive and known interventions to decrease the fetal risk due to Toxoplasma gondii infection. We reported herein a case series, with variable neurological and systemic compromise (respiratory distress, hepatosplenomegaly, enterocolitis, brain calcifications, thrombocytopenia, ascites, shock), even fatal, calling for awareness about the fact that despite the Zika epidemics in 2015-2016 in Brazil, Colombia and other countries, precisely toxoplasmosis, is a differential diagnosis still prevalent in these territories, that can leds to severe consequences, with neurological disability and risk of ocular damage, even lately. Additionally, with varieties of T. gondii with more aggressive patterns in Latin America, which make worse those cases, including also a higher risk of death.
Publication metrics
Metrics
Sustainable Development Goals
- SDG 3 Good Health and Well
